Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT05928312
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-20
First Post:
2023-06-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
Sponsor:
Zhejiang Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HMPL-013-FLAG-C127
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None